Is It Time To Revisit Abbott Laboratories (ABT) After This Year’s Share Price Slump?
If you are wondering whether Abbott Laboratories at around US$91.07 is a bargain or a value trap, you will want to look closely at what the current valuation is really telling you. The stock has risen 3.7% over the past week and 8.0% over the past month, yet it remains down 26.7% year to date and down 30.3% over the last year, which raises fair questions about how sentiment and risk perception have shifted. Recent headlines have focused on Abbott Laboratories as a large healthcare player,...